Review
Jun 2026
AI-Driven Design Platforms of Next-Generation Antibody Therapeutics
Recent advances at the interface of AI and antibody drug discovery are highlighted, key methodological developments are discussed, and the challenges that remain in translating AI-driven strategies into clinical success are examined.
Ying-Jie Wang, Afsheen Saba, Yue Ran et al.
· Topics in current chemistry · 0 citations